hypercholesterolemia Flashcards

(47 cards)

1
Q

cholesterol

A

steroid released by the liver and intestines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cholesterol function

A

regulates cell membrane fluidity and helps produce vitamin D, steroids and bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

triglyceride pathway

A

triglycerides get transported by VLDL from the liver or chylomicrons from the intestines to adipose tissue for energy and storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cholesterol pathway

A

cholesterol gets transported by LDL for plasma membranes and steroid synthesis or HDL for excess to be converted into bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

atherosclerosis

A

lipid deposition and plaque reaches critical point where disruption occurs and overlying thrombus forms which obstructs blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hypercholesterolemia causes (8)

A

diabetes, hyperthyroidism, pregnancy, menopause, CKD, liver disease, gout, FH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

normal total cholesterol

A

<5 mmol/L or <200 mg/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

normal HDL

A

> 1 mmol/l or 40-60 mg/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

normal LDL

A

<3 mmol/l or <100 mg/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

normal non-HDL

A

<4 mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

normal triglycerides

A

<2.3 mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

familial hypercholesterolemia

A

autosomal dominant disorder involving high LDL-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

heterozygous familial hypercholesterolemia

A

inherited mutation from one parent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

homozygous familial hypercholestrolemia

A

inherited mutation from both parents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hypercholesterolemia diagnosis

A

total cholesterol >7.5 mmol, check personal or family history of premature CHD, check SBC or DLCN criteria and refer to DNA testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hypercholesterolemia monitoring

A

full lipid profile, liver function tests, renal function, HbA1C, TFTs, creatine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

full lipid profile

A

aim for >40% reduction in non-HDL-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

liver function test

A

do not start statins if transaminases >3x upper limit, repeat at 3 months and 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

renal function test

A

low statin dose if severe impairment

20
Q

haemoglobin A1C test

A

can diagnose diabetes

21
Q

thyroid function test

A

can diagnose hypothyroidism

22
Q

creatine kinase

A

low statin dose if raised <5x upper limit and persistent muscle pain prior to starting; stop statin if >5x upper limit or experiencing pain

23
Q

statins function

A

reduce cholesterol synthesis in the liver by inhibiting HMG-CoA reductase

24
Q

high-intensity regimen

A

statin dose that reduces LDL-C by >50%

25
primary prevention drug
atorvastatin (20mg) daily
26
primary prevention aim
reduce non-HDL-C by >40%
27
secondary prevention drug
atorvastatin (80mg) daily, provided after a CV event
28
secondary prevention aim
reduce LDL-C to <2mmol/l or non-HDL-C to <2.6 mmol/l
29
atorvastatin contraindications
active liver disease, pregnancy, breastfeeding, antiviral drug interactions
30
atorvastatin side effects
nausea, indigestion, headaches, nosebleeds, sore throat, cold-like symptoms, constipation, flatulence, diarrhoea
31
ezetimibe
inhibits cholesterol absorption at brush border of intestine causing increased LDL receptor expression on hepatocyte cell surface and more cholesterol removal
32
when to offer ezetimibe
primary hypercholestreolemia with side effects to statins
33
ezetimibe contraindications (3)
increased risk of gallstones, myopathy and rhabdomyolysis, moderate to severe liver impairment
34
ezetimibe side effects
hypertension, abdominal pain, diarrhoea, flatulence, increased ALT/AST, headaches, fatigue
35
bempedoic acid
inhibits cholesterol synthesis (combined with ezetimibe)
36
when to offer bempedoic acid
patients intolerant to statins or contraindicated and LDL-C levels unaffected by ezetimibe
37
bempedoic acid contraindications
gout, liver conditions, pregnant or breastfeeding
38
bempedoic acid side effects
anaemia, myopathy with statins, deranged LFTs, reduced eGFR, gout, extremity pain
39
when to offer icosapent ethyl
triglycerides >1.7 mmol/l and LDL-C 1.04-2.6 mmol/l and established CVD and already on statin
40
icosapent ethyl contraindications
allergic to fish, hepatic impairment, atrial fibrillation, bleeding risk
41
icosapent ethyl side effects
atrial fibrillation, bleeding, peripheral oedema, gout, musculoskeletal pain, constipation
42
inclisiran
increases LDL receptor recycling and expression on hepatocyte cell surface and more cholesterol removal
43
when to offer inclisiran
LDL 2.6 mmol/l and established CVD and already on maximal tolerated oral lipid lowering therapy
44
inclisiran warnings
high cost drug approval for hospital use and some GPs reluctant to prescribe
45
PCSK9 inhibitors
bind PCSK9 to prevent LDL receptor degradation on hepatocyte cell surface and more cholesterol removal
46
PCSK9 inhibitor examples
evolocumab, alirocumab
47
PCSK9 inhibitor warnings
expensive